METASTATIC GASTRIC CANCER: DESCRIPTION OF CLINICAL CASE


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The emergence of drug tegafur+gimeracil+oteracil (TGO) - oral fluoropyrimidine derivative - provided a new look on the treatment of patients with metastatic gastric cancer. Interest in the drug is confirmed by the mass of international studies that examined its effectiveness in combination with various drugs. Combination of TGO with cisplatin was found to be as effective as the 5-FU and cisplatin (difference in median overall and progression-free survival were not statistically significant) with much less significant toxicity. The best safety profile allows to consider this drug as a promising medicine for the treatment of patients.

Texto integral

Acesso é fechado

Sobre autores

M. Abramov

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH PhD, Senior Researcher at the Department of Chemotherapy and Combined Therapy of Malignant Tumors FSBI «RORC n.a. N.N. Blokhin» of RMH Moscow

K. Bardovskaya

Moscow State University n.a. M.V. Lomonosov Moscow

A. Mescheryakov

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH Moscow

B. Medvedeva

FSBI “Russian Oncological Research Center n.a. N.N. Blokhin" of RMH Moscow

Bibliografia

  1. Globocan. Stomach cancer. Estimated incidence, mortlaity and prevalence worlwide http:// globocan.iarc.fr/old/FactSheets/cancers/ stomach-new.asp#INCIDENCE1.
  2. Sanford M. S-1 (Teysuno): A Review of Its Use in Advanced Gastric Cancer In Non-Asian Populations. Drugs 2013; 73(8):845-55.
  3. Ajani J., Rodrieguez W., Bodoky G., Moiseyenko V., Lichinitser M., Gorbunova V., Vynnychenko I., Garin A., Lang I., Falcon S. Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/ Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial. J. Clin. Oncol. 2010;28(9): 1547-53.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies